You are here PRODUCTS >> CELL LINES >> iPSc & iPSc DERIVATIVES >> CANCER-DERIVED iPSc
PRODUCTS
Cancer-derived iPSc
Celther Polska offers iPS cells generated from cells obtained from patients with prostate or breast cancer. CLTH/iPSc-breast-cancer and CLTH/iPSc-prostate-cancer were established through reprogramming of cells derived from patients diagnosed with prostate or breast cancer.
These cells display pluripotency markers (TRA-1-60, TRA-1-81, NANOG, alkaline phosphatase activity).
These cells display pluripotency markers (TRA-1-60, TRA-1-81, NANOG, alkaline phosphatase activity).
Cell line
Celther Cat. No.:
CLTH/iPSc-breast cancer
CL 05018 - BC - CLTH
CLTH/iPSc-prostate cancer
CL 05018 - PC - CLTH
General Specifications
Form:
Frozen
Format:
Vial(s)
Species:
Human
Culture Type:
Adherent Cell Culture
Donor Source:
Single Donor
Number of Cells:
30 colonies
Tests Performed:
Sterility Testing (Bacteria & Fungi)
Regulatory Statement:
For Research Use Only. Not for use in diagnostic procedures.